contentsubscribe

12 issues of the online newsletter Nordic Life Science Careers.

NLS

June 22, 2017

Published: June 22, 2017

NanoEcho declared bankrupt

Swedish medtech company NanoEcho has been declared bankrupt after failing to find a solution to its strained financial situation.

Clinical Trials Medtech – October 14, 2026

Integrum’s OPRA implant shows high survival in Ukrainian war veterans

A study of Ukrainian combat veterans with limb loss reports 97.9% implant survival one year after completion of treatment with Integrum’s OPRA Implant System, a bone-anchored prosthesis.

Clinical Trials – October 14, 2026

Xbrane completes enrollment in pivotal nivolumab biosimilar trial

Swedish biosimilar developer Xbrane Biopharma has fully recruited the pivotal clinical trial of Xdivane, its biosimilar candidate to Bristol Myers Squibb’s cancer immunotherapy Opdivo (nivolumab).

Agreement – October 14, 2026

Zealand Pharma signs AI protein deal with Generate Biomedicines

Zealand Pharma has entered a collaboration and license agreement with Generate Biomedicines to develop AI-engineered multispecific protein therapeutics for obesity and other metabolic diseases. Generate is eligible for nearly USD 1.2 billion in milestones for the first two programs.